GlassScriptPhysician profile
Nabil Akkad
NPI 1477548485
$7,911.35
in general payments reported to CMS, 2019-2025
25 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,948 · 2020: $91.80 · 2021: $306 · 2022: $1,031 · 2023: $239 · 2024: $212 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908 · Travel and Lodging: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.76 |
| Travel and Lodging | $627.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,834.96 | 2019-2020 | |
| Biotissue Holdings INC. | $872.37 | 2025 | |
| Ethicon US, LLC | $513.82 | 2019-2025 | Echelon; Endopath, Echelon Endopath, Stratafix |
| Medtronic, INC. | $505.12 | 2021-2025 | Maxtack, Progrip, Interstim |
| Stryker Corporation | $470.75 | 2022-2025 | Molli |
| Rochester Medical Corporation | $156.99 | 2021-2022 | |
| Lexington Medical, INC. | $71.20 | 2022 | |
| Getinge USA Sales, LLC | $67.08 | 2020 | |
| Polynovo North America LLC | $54.63 | 2023-2024 | Novosorb Btm |
| Myriad Genetic Laboratories, INC. | $50.24 | 2022-2025 | Myrisk |
| Hologic INC | $39.51 | 2022 | |
| Ge Healthcare | $26.38 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.04 | 2025 | Exparel |
| Innovation Technologies INC | $24.62 | 2024 | Irrisept |
| Kci USA, INC. | $24.00 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.08 | 2022 | |
| Acell, INC. | $19.70 | 2019 | |
| Innocoll Pharmaceuticals Limited | $19.58 | 2021 | |
| Solventum Corporation | $19.23 | 2024 | Prevena |
| Elucent Medical | $17.47 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.08 | 2023 | Gattex |
| Covidien LP | $14.26 | 2019 | |
| Cashflow Solutions, LLC | $11.70 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Angiodynamics, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Akkad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.